The mTOR signaling pathway plays a critical role in immune regulation by integrating diverse environmental inputs in the TME, involving CD8+ and CD4+ lymphocytes, regulatory T cells (Tregs), macrophages, myeloid‐derived suppressor cells, endothelial cells, and tumor‐associated fibroblasts [15, 16, 17]. The gene discussed is MTOR; the disease is neoplasm.